A drug with the SMILES CCN(CC)S(=O)(=O)c1ccc(N2CCCC2)c(NC(=O)c2c(-c3ccccc3)noc2C)c1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 15.209%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCN(CC)S(=O)(=O)c1ccc(N2CCCC2)c(NC(=O)c2c(-c3ccccc3)noc2C)c1
CCN(CC)S(=O)(=O)c1ccc(N2CCCC2)c(NC(=O)c2c(-c3ccccc3)noc2C)c1
N-[5-(diethylsulfamoyl)-2-pyrrolidin-1-ylphenyl]-5-methyl-3-phenyl-1,2-oxazole-4-carboxamide